Piperacillin, Tazobactam
- Product NDC
- 25021-164
- 11-digit product format
- 250210164
- Labeler code
- 25021
- Product ID
- 25021-164_66203cc2-0948-4012-ae96-532463e614a0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Piperacillin Sodium, Tazobactam Sodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA065498
- Marketing category
- ANDA
- Marketing start
- 2011-06-16
- Marketing end
- 2023-07-31
- Substance
- PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- Active strength
- 2 g/10mL; g/10mL
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC],Penicillins [CS],beta Lactamase Inhibitors [MoA],beta Lactamase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-164-30 | 25021016430 | 10 VIAL in 1 CARTON (25021-164-30) > 10 mL in 1 VIAL | 10 vial | 2011-06-16 | 2023-07-31 | No | No | Current |